{"id":54467,"date":"2025-11-18T20:06:33","date_gmt":"2025-11-18T14:36:33","guid":{"rendered":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/"},"modified":"2025-11-18T20:06:33","modified_gmt":"2025-11-18T14:36:33","slug":"xpovior-selinexor-now-funded-in-quebec","status":"publish","type":"post","link":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/","title":{"rendered":"XPOVIO(R) (selinexor) Now Funded in Quebec"},"content":{"rendered":"

<\/p>\n

Oakville, Ontario–(Newsfile Corp. – November 18, 2025) – FORUS Therapeutics is pleased to announce that XPOVIO\u00ae<\/sup> (selinexor) is publicly funded in Quebec for the treatment of multiple myeloma as of November 6, 2025. Please see the following link for full funding criteria: Liste des m\u00e9dicaments fournis en \u00e9tablissement | R\u00e9gie de l’assurance maladie du Qu\u00e9bec (RAMQ) (https:\/\/www.ramq.gouv.qc.ca\/fr\/a-propos\/liste-medicaments fournis-etablissement<\/a>) and Liste des m\u00e9dicaments | R\u00e9gie de l’assurance maladie du Qu\u00e9bec (RAMQ) (https:\/\/www.ramq.gouv.qc.ca\/fr\/a-propos\/liste-medicaments<\/a>).<\/p>\n

“We are very pleased to have successfully concluded the INESSS process. This is a significant milestone to ensure that Quebec multiple myeloma patients have equitable access to XPOVIO,” said Kevin Leshuk, President and CEO of FORUS. <\/p>\n

“Myeloma Canada commends Quebec’s decision to fund XPOVIO for patients living with multiple myeloma,” said Martine Elias, M.Sc., CEO of Myeloma Canada. “As an innovative therapy with a novel mechanism of action for patients with early relapsed or refractory disease, XPOVIO offers renewed hope and expands the treatment armamentarium available to clinicians and patients.”<\/p>\n

About FORUS Therapeutics<\/b><\/p>\n

FORUS Therapeutics is a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer. Our mission is to bring solutions to cancer patients, caregivers, physicians and our partners by accelerating unique and important treatments that meaningfully enhance life.<\/p>\n

\n

For Further Information and Media Inquiries: <\/b>Kevin Leshuk, President and CEO, FORUS Therapeutics Inc. (media@forustherapeutics.com<\/a>)<\/p>\n<\/div>\n

Read on LinkedIn<\/a><\/p>\n

Read more on newsfile<\/a><\/p>\n

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.<\/b><\/p>\n

To view the source version of this press release, please visit https:\/\/www.newsfilecorp.com\/release\/274616<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Oakville, Ontario–(Newsfile Corp. – November 18, 2025) – FORUS Therapeutics is pleased to announce that XPOVIO\u00ae (selinexor) is publicly funded in Quebec for the treatment of multiple myeloma as of November 6, 2025. Please see the following link for full funding criteria: Liste des m\u00e9dicaments fournis en \u00e9tablissement | R\u00e9gie de l’assurance maladie du Qu\u00e9bec …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130],"tags":[],"class_list":["post-54467","post","type-post","status-publish","format-standard","","category-international"],"yoast_head":"\nXPOVIO(R) (selinexor) Now Funded in Quebec - Matribhumi Samachar English<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPOVIO(R) (selinexor) Now Funded in Quebec - Matribhumi Samachar English\" \/>\n<meta property=\"og:description\" content=\"Oakville, Ontario–(Newsfile Corp. – November 18, 2025) – FORUS Therapeutics is pleased to announce that XPOVIO\u00ae (selinexor) is publicly funded in Quebec for the treatment of multiple myeloma as of November 6, 2025. Please see the following link for full funding criteria: Liste des m\u00e9dicaments fournis en \u00e9tablissement | R\u00e9gie de l’assurance maladie du Qu\u00e9bec …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/\" \/>\n<meta property=\"og:site_name\" content=\"Matribhumi Samachar English\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T14:36:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/api.newsfilecorp.com\/newsinfo\/274616\/511\" \/>\n<meta name=\"author\" content=\"Saransh Kanaujia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saransh Kanaujia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/\",\"name\":\"XPOVIO(R) (selinexor) Now Funded in Quebec - Matribhumi Samachar English\",\"isPartOf\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\"},\"datePublished\":\"2025-11-18T14:36:33+00:00\",\"dateModified\":\"2025-11-18T14:36:33+00:00\",\"author\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\"},\"breadcrumb\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/matribhumisamachar.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPOVIO(R) (selinexor) Now Funded in Quebec\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/\",\"name\":\"Matribhumi Samachar English\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\",\"name\":\"Saransh Kanaujia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"caption\":\"Saransh Kanaujia\"},\"description\":\"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.\",\"sameAs\":[\"https:\/\/matribhumisamachar.com\/en\"],\"url\":\"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPOVIO(R) (selinexor) Now Funded in Quebec - Matribhumi Samachar English","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/","og_locale":"en_US","og_type":"article","og_title":"XPOVIO(R) (selinexor) Now Funded in Quebec - Matribhumi Samachar English","og_description":"Oakville, Ontario–(Newsfile Corp. – November 18, 2025) – FORUS Therapeutics is pleased to announce that XPOVIO\u00ae (selinexor) is publicly funded in Quebec for the treatment of multiple myeloma as of November 6, 2025. Please see the following link for full funding criteria: Liste des m\u00e9dicaments fournis en \u00e9tablissement | R\u00e9gie de l’assurance maladie du Qu\u00e9bec …","og_url":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/","og_site_name":"Matribhumi Samachar English","article_published_time":"2025-11-18T14:36:33+00:00","og_image":[{"url":"https:\/\/api.newsfilecorp.com\/newsinfo\/274616\/511"}],"author":"Saransh Kanaujia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saransh Kanaujia","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/","url":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/","name":"XPOVIO(R) (selinexor) Now Funded in Quebec - Matribhumi Samachar English","isPartOf":{"@id":"https:\/\/matribhumisamachar.com\/en\/#website"},"datePublished":"2025-11-18T14:36:33+00:00","dateModified":"2025-11-18T14:36:33+00:00","author":{"@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1"},"breadcrumb":{"@id":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/matribhumisamachar.com\/en\/2025\/11\/18\/xpovior-selinexor-now-funded-in-quebec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/matribhumisamachar.com\/en\/"},{"@type":"ListItem","position":2,"name":"XPOVIO(R) (selinexor) Now Funded in Quebec"}]},{"@type":"WebSite","@id":"https:\/\/matribhumisamachar.com\/en\/#website","url":"https:\/\/matribhumisamachar.com\/en\/","name":"Matribhumi Samachar English","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1","name":"Saransh Kanaujia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","caption":"Saransh Kanaujia"},"description":"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.","sameAs":["https:\/\/matribhumisamachar.com\/en"],"url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/"}]}},"_links":{"self":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/54467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/comments?post=54467"}],"version-history":[{"count":0,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/54467\/revisions"}],"wp:attachment":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/media?parent=54467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/categories?post=54467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/tags?post=54467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}